DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 6.383
EU - Europa 3.220
AS - Asia 3.045
SA - Sud America 361
Continente sconosciuto - Info sul continente non disponibili 40
AF - Africa 31
OC - Oceania 5
Totale 13.085
Nazione #
US - Stati Uniti d'America 6.261
SG - Singapore 1.161
CN - Cina 807
IT - Italia 631
IE - Irlanda 576
RU - Federazione Russa 516
TR - Turchia 422
SE - Svezia 351
BR - Brasile 329
DE - Germania 285
HK - Hong Kong 285
GB - Regno Unito 256
UA - Ucraina 225
VN - Vietnam 217
FR - Francia 148
FI - Finlandia 133
CA - Canada 76
IN - India 31
BE - Belgio 29
BD - Bangladesh 23
JP - Giappone 16
MX - Messico 16
AR - Argentina 15
PL - Polonia 15
TW - Taiwan 14
ZA - Sudafrica 13
ES - Italia 12
NL - Olanda 12
IQ - Iraq 10
PK - Pakistan 8
JM - Giamaica 7
MA - Marocco 7
SA - Arabia Saudita 7
AT - Austria 6
IL - Israele 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
EC - Ecuador 5
EU - Europa 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
AU - Australia 3
BS - Bahamas 3
EE - Estonia 3
KE - Kenya 3
MY - Malesia 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
JO - Giordania 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 13.050
Città #
Jacksonville 872
Singapore 753
Chandler 685
Ashburn 656
San Jose 627
Dublin 575
Dallas 353
Council Bluffs 349
Boardman 291
Hong Kong 278
Santa Clara 255
Izmir 191
Nanjing 186
San Mateo 168
Milan 125
Lawrence 109
Princeton 109
The Dalles 107
Moscow 106
Wilmington 104
Ann Arbor 101
L’Aquila 94
São Paulo 86
New York 81
Lauterbourg 80
Ho Chi Minh City 69
Hangzhou 59
Nanchang 58
Woodbridge 54
Beijing 52
Hanoi 50
Rome 45
Hefei 43
Los Angeles 42
Shenyang 42
Verona 38
Hebei 31
Tianjin 31
Toronto 31
Des Moines 30
Mountain View 29
Brussels 28
Changsha 27
Jiaxing 25
Jinan 25
L'aquila 25
Kunming 24
Seattle 23
Naples 22
Helsinki 18
Montreal 18
Frankfurt am Main 17
Ningbo 17
Atlanta 16
Miano 16
Munich 16
Brooklyn 15
Tokyo 15
Zhengzhou 15
Da Nang 14
Norwalk 14
Taipei 14
Phoenix 13
Shanghai 13
Düsseldorf 12
Warsaw 12
Denver 11
Haiphong 11
Johannesburg 11
Lanzhou 11
Manchester 11
Poplar 11
San Francisco 11
London 10
Taizhou 10
Chennai 9
Newark 9
Turku 9
Boston 8
Orem 8
Philadelphia 8
Rio de Janeiro 8
Turin 8
Amsterdam 7
Guangzhou 7
Las Vegas 7
Perugia 7
Stockholm 7
Auburn Hills 6
Chicago 6
Falkenstein 6
Florence 6
Bologna 5
Columbus 5
Fremont 5
Genoa 5
Goiânia 5
Mexico City 5
Nuremberg 5
Palermo 5
Totale 8.762
Nome #
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell chronic lymphoproliferative disorders 257
HSV-TK gene as a potential tool for generating a controlled graft-versus-host/graft-versus-leukemia effect 215
Activated T lymphocytes exert an anti-tumoral effect against autologous chronic lymphatic leukemia cells 195
HSV-TK transduced T-lymphocytes: in vitro and in vivo studies 189
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 183
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 178
Notch1 modulates MSC-mediated regulatory T cell induction 172
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 172
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 168
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 168
Constitutive phosphorilation of the active Notch1 intracellular domain in chronic lymphocytic leukemia with Notch1 mutation 164
The NOTCH1/CD39 axis: a Treg trip-switch for GvHD. 160
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 156
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: adaptation to hypoxia or prevention from oxidative stress? 154
Adoptive immunotherapy with Treg and Tcon separates GvL from GvHD in HLA-haploidentical stem cell transplantation. 149
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 148
NOTCH signalling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 147
Tregs prevent GvHD and promote immune reconstitution in HLA-haploidentical transplantation. 145
A revised Notch1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 143
HLA-haploidentical transplantation with regulatory and conventional T cell adoptive immunotherapy prevents acute leukemia relapse 141
T lymphocytes transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparing four different infection protocols 140
T cell pathway deficiencies in Chronic Lymphocityc Leukemia: partial restoration with OKT3/IL-2 activation 140
Notch1 PEST domain mutation is an adverse prognostic factor in B-CLL 138
Role of DNA-demethylating agent 5-azacitidine in maintenance of transgene expression in SCID mice. A study performed with a bicistronic retroviral vector 137
T regulatory cell separation for clinical application 135
B-chronic lymphocytic leukemia exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha 135
"Designed" grafts for HLA-haploidentical stem cell transplantation 134
Transformation by Retroviral Vectors of Bone Marrow-Derived Mesenchymal Cells Induces Mitochondria-Dependent cAMP-Sensitive Reactive Oxygen Species Production 134
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 133
T-lymphocytes function after retroviral mediated thymidine kinase gene transfer and G418 selection 130
The iron chelator deferasirox affects redox signalling in hematopoietic stem/progenitor cells. 130
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and ehanced green fluorescence protein genes in primary T lymphocytes 126
Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation? 126
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation 125
Beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocytes reaction 125
In vivo demethylation of a MoMULV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5-azacytidine 125
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma. 124
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 124
Effect of trichostatin A and 5'-azacytidine on transgene reactivation in U937 transduced cells 124
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation 122
The rs5743836 polimorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 121
Adoptive immunotherapy with Tregs and Tcons rebuilds post transplant immunity and is associated with low TRM in HLA-haploidentical transplantation 121
Notch and NF-kB interplay in Chronic Lymphocytic Leukemia is independent of genetic lesion 120
Melphalan alone versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for multiple myeloma 119
Immunoselection and clinical use of T regulatory cells in HLA haploidentical stem cell transplantation 119
To breath or not to breath: the hematopoietic stem/progenitor dilemma 119
G-CSF induced thrombocytopenia in a healthy donor 118
evidence of jak2 val617phe positive essential thrombocythemia with splancin thrombosis during estroprogestinic treatment 118
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis 118
Transduction of beta-galactosidase gene into U937 cell line: in vitro and in vivo evidence of stably expression of the transgene 117
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 116
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 115
5-azacytidine and prevention of proviral DNA hypermethylation: implication for gene therapy 115
5-azacytidine prevents transgene methylation in vivo 115
“Suicide” gene transduction into U937 leukemic cell line 115
CD34+ cells from AML with mutated NPM1 harbor cytoplasic muatated nucleophosmin and generate leukemia in immunocompromised mice 114
Homing and kinetics of thymidine kinase transduced T lymphocytes in NOD/SCID mice 114
Naive and Memory T Regulatory Cells Respond to Mesenchymal Cells Regulation 114
Next gebneration in HLA-haploidentical HSCT. 113
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone 112
Effects of G418 on thymidine kinase/neomycine resistance transduced T lymphocytes 112
Adoptive immunotherapy with Tregs and Tcons promote a GvL effect in absence of GvHD in HLA-haploidentical transplantation. 111
Treating two concurrent B and T cell lymphoid neoplasms with alemtuzumab monotherapy 109
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma. 108
PET imaging of mesenchymal stem cells carrying the HSV-1 thymidine kinase reporter gene. Comaprison between adenoviral and retroviral infection 108
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis. 108
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 106
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 105
Graft engineering for allogenic haploidentical stem cell transplantation 105
Activated autologous T cells exert an anti B-cell Chronic Lymphatic Leukemia effect in vitro and in vivo 104
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation 103
Homing and survival of thymidine kinase human T cells in NOD/SCID mice 103
Expression of thymidine kinase and LacZ genes in SCID mice by using a new retroviral vector. 103
Retroviral mediated gene transfer into T lymphocytes stimulated by either PHA/IL-2 or a mixed lymphocyte reaction 103
Mesenchymal cells recruit and regulate T regulatory cells 102
Primary eyelid plasmacytoma 102
Clonable T lymphocytes after thymidine kinase transduction and ganciclovir treatment 102
Immuno-magnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications 101
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study. 101
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 101
Adoptive immunotherapy with Tregs and Tcons ensures low TRM and a low incidence of post transplant leukaemia relapse after HLA haploidentical transplants for acute leukaemia. 101
Adoptive immunotherapy with Tregs prevents GvHD and favours immune reconstitution after HLA haploidentical transplants for hematological malignancies 100
Activated autologous T lymphocytes exert an anti-tumoral effect against chronic lymphatic leukemia (CLL) cells 100
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes 100
Large-scale generation of human allodepleted anti 3rd party lymphocytes 98
A microelectronic DNA chip detects the V617 JAK2 mutation in myeloproliferative disorders 97
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 97
Retroviral trasduction of the beta-galactosidase gene in natural killer and B lymphocytes: an analisys of the ability of this vector to infect lymphocyte subpopulations 97
Mesenchymal cells: a vehicle for gene therapy 97
Retroviral transfer of Herpes Simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 96
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and support immunological reconstitution after HSCT in NOD/SCID mice 96
NeoR-based transduce T lymphocytes detected by real time quantitative polymerase chain reaction 96
Does 5-azacytidine increase transgene expression? Results of a preliminary in vivo study 95
Interleukin7 engineered mesenchymal cells: in vitro effects on naive T cell population 94
Interleukin 7 engineered stromal cells: a new approach for hastening naive T cell recruitment 94
A Microelectronic DNA Chip Detects the V617F JAK-2 Allelic Ratio in Myeloproliferative Disorders 94
MtDNA muattion associated with mitochondrial dysfunction in megacaryoblastic leukaemic cells 92
IL-7 transduced mesenchymal cells home to lymphoid organs and improve immunological reconstitution in NOD/SCID mice. 91
Human mesenchymal cells regulates naive and memory T regulatory cells 90
Homing and survival of thymidine kinase transduced T lymphocytes into NOD/SCID mice. 89
Totale 12.355
Categoria #
all - tutte 51.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 0 55 22 0 16 40 32 26 50 165
2022/20231.916 147 102 45 187 213 216 0 128 791 10 44 33
2023/2024457 154 33 21 89 28 47 19 29 0 7 12 18
2024/20251.882 118 21 176 24 206 202 255 167 370 77 126 140
2025/20263.285 111 310 192 420 322 300 692 91 307 275 229 36
2026/20271.551 68 481 310 692 0 0 0 0 0 0 0 0
Totale 13.085